Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the Knee
Trial details
- Registry ID
- NCT04120402
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of EP-104IAR in Patients With Osteoarthritis of the KneeNCT04120402 | EPRX | Phase 2 | Completed | 2023-05-17Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |